Consumer wellness and personal care company Cupid Ltd has announced its financial results for the September quarter, reporting that its net profit more than doubled to ₹56 crore compared to ₹24 crore in the corresponding period of the previous year. The growth was largely attributed to strong demand across the company's product portfolio.
Alongside the rise in net profit, the company's income also more than doubled, reaching ₹209 crore compared to ₹90 crore in the same period last year. Profit before tax registered an increase, rising to ₹73 crore from ₹32 crore.
According to Cupid's presentation, the domestic business contributed ₹225 crore, accounting for 67 percent of H1 FY27 sales, up from 41 percent in FY26. The performance was led by the Consumer Healthcare and FMCG business at ₹167 crore, which represented 49 percent of sales, reflecting the growing scale and contribution of the company’s consumer portfolio. Meanwhile, the international business contributed ₹113 crore, representing 33 percent of H1 FY27 sales, supported by institutional demand.
In addition to its core operations, Cupid has been involved in strategic investments. The company was allotted 1.01 crore convertible warrants of Baazar Style Retail (Style Baazar), reflecting a total investment commitment of ₹332 crore. In May, Cupid converted 15 lakh warrants into equity shares at ₹328 per share, valued at ₹49 crore. Subsequently, the company converted another 30 lakh warrants in September and October, taking total conversions to 45 lakh warrants with an aggregate conversion value of ₹148 crore.
Cupid has deployed ₹193 crore, including upfront consideration for the transaction. The remaining 56 lakh warrants are pending conversion, which will require an additional investment of about ₹138 crore upon conversion.
Aditya Kumar Halwasiya, Chairman and Managing Director of Cupid, stated that the financial performance reflects the growing scale of the business both in India and abroad. He noted that price revisions across the export portfolio have supported realisations, while the company remains focused on strengthening global partnerships and its market presence.
Halwasiya also highlighted an exclusive partnership with V2 Retail, which provides dedicated retail space over 425 stores and is expected to generate a revenue contribution of about ₹400 crore over the next 12 months. Additionally, the company is evaluating a medical-devices manufacturing project in West Bengal to further broaden its healthcare manufacturing base.
"Cupid's strong Q2 performance demonstrates the impact of balancing domestic consumer portfolio growth with strategic international demand. Their retail partnerships and disciplined capital deployment, such as the phased conversion of warrants in Baazar Style Retail, indicate a measured approach to scale. Expanding into medical devices and leveraging dedicated retail spaces will be key areas to watch as the company builds on this momentum." — Dr. Shishir Gupta, Founder & CEO, StartupLanes
Recent StartupLanes Articles
Browse through our 30 latest publications on venture capital, startups, and angel investing.